Adrien Bernstein
Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai
Papers
3
Total Citations
32
H-Index
3
About
Adrien Bernstein is a urologic surgeon and researcher whose work focuses on refining risk stratification and surgical outcomes in prostate cancer. His most cited study, a 2016 assessment of men aged 50 or younger undergoing robotic prostatectomy (18 citations), challenged assumptions about early-onset disease by demonstrating that young patients can achieve favorable clinicopathological and functional outcomes without compromising oncologic control. Bernstein further advanced precision medicine in a 2017 investigation of D’Amico intermediate-risk patients (7 citations), revealing that the primary and secondary Gleason scores within biopsy specimens drive significant heterogeneity in outcomes after radical prostatectomy—a finding that helps tailor treatment intensity for this ambiguous risk group. His 2012 work on robot-assisted laparoscopic prostatectomy in patients with prior surgical history (7 citations) underscores his commitment to expanding surgical candidacy through multidisciplinary planning. By dissecting how tumor biology and patient history interact with robotic techniques, Bernstein has provided actionable insights that bridge surgical innovation with personalized risk assessment. His research continues to inform how clinicians counsel patients on the balance between cancer control and quality of life, particularly in younger and intermediate-risk populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3